CD70 and ovarian cancer: A humanized CD70 targeting (SGN-75) ADC was effective at killing a CD70-expressing ovarian cancer cell line, but it had no effect on the pancreatic cancer cell lines tested (Panc-1 and MIA PaCa-2) due to low or no CD70 expression on these lines, respectively.